These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
333 related items for PubMed ID: 25552929
1. Decrease of let-7f in low-dose metronomic Paclitaxel chemotherapy contributed to upregulation of thrombospondin-1 in breast cancer. Tao WY, Liang XS, Liu Y, Wang CY, Pang D. Int J Biol Sci; 2015; 11(1):48-58. PubMed ID: 25552929 [Abstract] [Full Text] [Related]
2. Low-dose metronomic paclitaxel chemotherapy suppresses breast tumors and metastases in mice. Jiang H, Tao W, Zhang M, Pan S, Kanwar JR, Sun X. Cancer Invest; 2010 Jan; 28(1):74-84. PubMed ID: 20001297 [Abstract] [Full Text] [Related]
3. Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol. Asghari F, Haghnavaz N, Shanehbandi D, Khaze V, Baradaran B, Kazemi T. Adv Clin Exp Med; 2018 Jul; 27(7):941-945. PubMed ID: 30019863 [Abstract] [Full Text] [Related]
5. Low-dose metronomic chemotherapy of paclitaxel synergizes with cetuximab to suppress human colon cancer xenografts. Zhang M, Tao W, Pan S, Sun X, Jiang H. Anticancer Drugs; 2009 Jun; 20(5):355-63. PubMed ID: 19318912 [Abstract] [Full Text] [Related]
6. MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer. Li Y, Zhang L, Dong Z, Xu H, Yan L, Wang W, Yang Q, Chen C. Pathol Res Pract; 2021 Apr; 220():153405. PubMed ID: 33756128 [Abstract] [Full Text] [Related]
12. Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? Amodeo V, Bazan V, Fanale D, Insalaco L, Caruso S, Cicero G, Bronte G, Rolfo C, Santini D, Russo A. Expert Opin Ther Targets; 2013 Nov; 17(11):1249-61. PubMed ID: 24053448 [Abstract] [Full Text] [Related]
13. MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR. Zhang B, Zhao R, He Y, Fu X, Fu L, Zhu Z, Fu L, Dong JT. Oncotarget; 2016 Feb 02; 7(5):5702-14. PubMed ID: 26744318 [Abstract] [Full Text] [Related]
17. Metronomic docetaxel chemotherapy inhibits angiogenesis and tumor growth in a gastric cancer model. Wu H, Xin Y, Zhao J, Sun D, Li W, Hu Y, Wang S. Cancer Chemother Pharmacol; 2011 Oct 02; 68(4):879-87. PubMed ID: 21290245 [Abstract] [Full Text] [Related]
18. STAT3 is required for MiR-17-5p-mediated sensitization to chemotherapy-induced apoptosis in breast cancer cells. Liao XH, Xiang Y, Yu CX, Li JP, Li H, Nie Q, Hu P, Zhou J, Zhang TC. Oncotarget; 2017 Feb 28; 8(9):15763-15774. PubMed ID: 28178652 [Abstract] [Full Text] [Related]
19. Dose-dependent differential mRNA target selection and regulation by let-7a-7f and miR-17-92 cluster microRNAs. Shu J, Xia Z, Li L, Liang ET, Slipek N, Shen D, Foo J, Subramanian S, Steer CJ. RNA Biol; 2012 Oct 28; 9(10):1275-87. PubMed ID: 22995834 [Abstract] [Full Text] [Related]
20. Lin28 mediates paclitaxel resistance by modulating p21, Rb and Let-7a miRNA in breast cancer cells. Lv K, Liu L, Wang L, Yu J, Liu X, Cheng Y, Dong M, Teng R, Wu L, Fu P, Deng W, Hu W, Teng L. PLoS One; 2012 Oct 28; 7(7):e40008. PubMed ID: 22808086 [Abstract] [Full Text] [Related] Page: [Next] [New Search]